RAPT Therapeutics Announces Pricing of Public Offering of Common Stock Portfolio News / By Karina Tin June 15, 2021
RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis Portfolio News / By Karina Tin June 14, 2021
Synthekine Announces $107.5 Million Oversubscribed Series B Financing to Support Lead Programs to Clinical Proof of Concept, Advance Preclinical Programs and Platform Portfolio News / By Karina Tin June 10, 2021
eFFECTOR Therapeutics Doses First Patient in Phase 2b KICKSTART Clinical Trial Portfolio News / By Karina Tin June 9, 2021
Ribon Therapeutics Announces Oral Presentation of Positive Interim Data from Phase 1 Trial of RBN-2397 in Patients with Advanced Solid Tumors at 2021 ASCO Annual Meeting Portfolio News / By Karina Tin June 4, 2021
ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel Portfolio News / By Karina Tin June 02, 2021
Constellation Pharmaceuticals to be Acquired by MorphoSys Portfolio News / By Karina Tin June 2, 2021
Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease Portfolio News / By Karina Tin June 2, 2021
Kallyope Inc. Appoints Patrick Flanigan as Chief Financial Officer Portfolio News / By Karina Tin June 1, 2021
